<p>ScN2a cells were treated with the compounds belonging to the L (panels A and B), G, R', R and Y (panel C) series at 10 µM. After four days of incubation with the compounds, cells were lysed, treated with PK and PrP<sup>Res</sup> was detected in the dot-blot assay with anti-PrP antibody (R30). Control bar (medium) represents intensity density of the blot from wells without compound addition, corresponding to 100% of PrP<sup>Res</sup> content. Quantification of the assay was done by integration of the density of each dot using ImageJ software. All bars had <b>*</b><i>P</i><0.05 in relation to control.</p
<p>N2a/22L cells were incubated with purified Mabs for 96 hrs. Cells were harvested and PK-treated l...
<p>PrP<sup>Res</sup> was detected using R20 antiserum (epitope: 218–231). Brain homogenates from ScB...
<p>PK1 cells were infected with brain-derived, swa-sensitive RML prions or swa-dependent prions deri...
<p>ScN2a cells were treated with compounds from the R and R' (panel A); G (panel B); D, J and Y (pan...
<p>ScN2a cells were grown for 4-well plates in the presence of compounds from the R series at 1, 5, ...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
<p>PrP<sup>res</sup> after cell screening with test compounds and subsequent cell lysis for western ...
<p>N2a-3 cells were cultured with an anti-prion compound at the EC<sub>65</sub> (mAb 44B1, 0.4 µg/ml...
<p>Note the unchanging 13kd band of PrP-res that is a unique characteristic of Asiatic FU-CJD agent ...
<p>ScN2a-3-22L cells grown on a chambered coverglass for 48 h were cultured with or without an anti-...
<p>N2a cells treated with liposomes alone (panels a–d), or LSPCs containing Alexa 488-labeled siRNAs...
<p>N2a-3 cells or ScN2a-3-22L cells were cultured with or without an anti-prion compound at the EC<s...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
<p>(A) N2aFK cells were treated for 48 h with 0.01 to 1 μM MG132 and 0.1 to 10 nM epoxomicin (Epo) a...
<p>N2a/22L cells were incubated with purified Mabs for 96 hrs. Cells were harvested and PK-treated l...
<p>PrP<sup>Res</sup> was detected using R20 antiserum (epitope: 218–231). Brain homogenates from ScB...
<p>PK1 cells were infected with brain-derived, swa-sensitive RML prions or swa-dependent prions deri...
<p>ScN2a cells were treated with compounds from the R and R' (panel A); G (panel B); D, J and Y (pan...
<p>ScN2a cells were grown for 4-well plates in the presence of compounds from the R series at 1, 5, ...
<p>(A) ScN2a-3-22L cells grown on 12-well plates were cultured in the presence or absence of mAb 44B...
<p>PrP<sup>res</sup> after cell screening with test compounds and subsequent cell lysis for western ...
<p>N2a-3 cells were cultured with an anti-prion compound at the EC<sub>65</sub> (mAb 44B1, 0.4 µg/ml...
<p>Note the unchanging 13kd band of PrP-res that is a unique characteristic of Asiatic FU-CJD agent ...
<p>ScN2a-3-22L cells grown on a chambered coverglass for 48 h were cultured with or without an anti-...
<p>N2a cells treated with liposomes alone (panels a–d), or LSPCs containing Alexa 488-labeled siRNAs...
<p>N2a-3 cells or ScN2a-3-22L cells were cultured with or without an anti-prion compound at the EC<s...
During prion diseases, a normally benign, host protein, denoted PrP(C), undergoes alternative foldin...
<p>(A) rPrP PMCA reactions seeded with rPrP-res and serially propagated in the presence of 30 µg/ml ...
<p>(A) N2aFK cells were treated for 48 h with 0.01 to 1 μM MG132 and 0.1 to 10 nM epoxomicin (Epo) a...
<p>N2a/22L cells were incubated with purified Mabs for 96 hrs. Cells were harvested and PK-treated l...
<p>PrP<sup>Res</sup> was detected using R20 antiserum (epitope: 218–231). Brain homogenates from ScB...
<p>PK1 cells were infected with brain-derived, swa-sensitive RML prions or swa-dependent prions deri...